Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals, Inc. is listed today as Corvus Pharmaceuticals, Inc.: market value, financials and filings are on its company page.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Sep 2015 | $75 M | No. 2 | $50 to $250 million | equity | SEC | |
| Nov 2014 | $13 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Corvus Pharmaceuticals, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2015).
SEC Form D · Sep 2015
The industry group it chose in its notices: Other Health Care.
SEC Form D · Sep 2015
That is all the official record says: Corvus Pharmaceuticals, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services of Corvus Pharmaceuticals, Inc. are on record.
Investors#
3 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Adams Street Partners LLC | Fund or asset manager | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2016) | SEC Form 3 |
| Novo Holdings A/s | Fund or asset manager | not stated | not stated | Held Series A and B preferred stock, 10% owner (Form 3, 2016) | SEC Form 3 |
| Orbimed Advisors LLC | Fund or asset manager | not stated | not stated | Held Series A and B preferred stock, 10% owner, director (Form 3, 2016) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 33 investors.
Largest shareholders today
Institutions holding Corvus Pharmaceuticals, Inc. shares, as of Sep 30, 2026.
- Orbimed Advisors LLC$83 M8.49%
- BlackRock, Inc.$82 M8.42%
- State Street Corp$38 M3.95%
- Vanguard Capital Management LLC$38 M3.93%
- Hood River Capital Management LLC$38 M3.93%
- Adams Street Partners LLC$38 M3.88%
- Price T Rowe Associates Inc /MD/$35 M3.62%
- Wellington Management Group LLP$33 M3.38%
- Vivo Capital, LLC$32 M3.33%
- Perceptive Advisors LLC$29 M2.98%
- Deep Track Capital, LP$29 M2.95%
- Braidwell LP$22 M2.29%
- Foresite Capital Management VI LLC$21 M2.17%
- Geode Capital Management, LLC$21 M2.13%
- Fisher Asset Management, LLC$12 M1.23%
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Leiv P. Lea | Executive officer | Sep 2015 |
| Richard A. Miller | Executive officer | Sep 2015 |
| Leiv G. Lea | Executive officer | Dec 2014 |
| Elisha (Terry) P. Gould | Director | Sep 2015 |
| Peter P. Moldt | Director | Sep 2015 |
| Peter P. Thompson | Director | Sep 2015 |
| Richard A. Miller | Director | Sep 2015 |
| Peter G. Thompson | Director | Dec 2014 |
| Terry G. Gould | Director | Dec 2014 |
Went public since 2016. Its SEC number is that of a company listed on a stock exchange.